Previous studies have shown that the differentiation potential declines with the age of progenitor cells and is linked to altered levels of senescence markers. The purpose of this study was to test whether senescence marker p16 affects age-related tenogenic differentiation in tendon stem/progenitor cells (TSPCs). Young and aged TSPCs were isolated from young/healthy and aged/ degenerated human Achilles tendons, respectively. Cellular aging and capacity for tenogenic differentiation were examined. The results showed that the tenogenic differentiation capacity of TSPCs significantly decreases with advancing age. TSPCs from elderly donors showed upregulation of senescence-associated β-galactosidase and p16 and concurrently a decrease in Type I collagen concentration and in the expressions of tendon-related markers: Scx, Tnmd, Bgn, Dcn, Col1, and Col3. Overexpression of p16 significantly inhibited tenogenic differentiation of young TSPCs. Analysis of the mechanism revealed that this effect is mediated by microRNA-217 and its target EGR1. These results indicated that p16 inhibits tenogenic differentiation of TSPCs via microRNA signaling pathways, which may serve as a potential target for the prevention or treatment in the future.
Introduction
Aging is thought to be a primary risk factor for tendon disorders. Tendons become more prone to tissue degeneration and subsequent injury with advancing age [1] . Despite recent advances in pharmacological and surgical treatments, it is still difficult to recover damaged tendons to their original levels of biological and biomechanical characteristics [2] . Tendon stem/progenitor cells (TSPCs) have been isolated from adult tendons of humans and vertebrate animals, including the horse, rabbit, rat, and mouse [3] [4] [5] . TSPCs are capable of selfrenewal with a multilineage differentiation potential and therefore provide a potent cell source for regeneration and replacement of damaged tendons [6] . TSPC senescence may lead to age-related tendon disorders and impair tendon regeneration and replacement capacity [7] . Nonetheless, the detailed mechanism underlying age-related tendon regeneration is still unclear.
Some studies have shown that the differentiation potential declines with age and with passages of mesenchymal stem cells (MSCs) in culture, and the loss of this potential is associated with altered levels of senescence markers [8, 9] . For example, Liu et al. [10] found that the bone mass and osteogenic differentiation capacity of MSCs significantly decrease with advancing age. Overexpression of p53 inhibits osteogenesis in young MSCs in culture and upon implantation into NOD/SCID mice. Recent research also showed that the tenogenic differentiation potential of TSPCs can decline with aging [11, 12] . Meanwhile, aged TSPCs showed substantial upregulation of senescence marker p16 INK4A [13] . It is well known that osteogenic and adipogenic differentiation capacity is significantly restored by a p16 knockdown in aging MSCs [14] . p16 is also a modulator of gene expression. The most appealing hypothesis is the possible implication of microRNAs (miRNAs) in this p16-dependent post-transcriptional regulation [15] . miRNAs are a class of non-coding RNAs that regulate gene expression posttranscriptionally via complementary base pairing with the 3′-untranslated region (UTR) of target mRNAs, causing their degradation or suppression of translation [16] . miRNAs are involved in multiple biological processes, such as cellular differentiation, proliferation, apoptosis, and senescence [17] . Alterations in miRNA expression levels have been linked to various human diseases, including tendinopathy [18] .
In the present study, we tested whether the change in the tenogenic differentiation potential of TSPCs with age is related to the p16 expression level. We found that aged TSPCs showed decreased tenogenic differentiation capacity and upregulation of p16. Overexpression of p16 in young TSPCs inhibited the tenogenic differentiation of TSPCs. Furthermore, we elucidated the tentative underlying mechanism: p16 inhibits the tenogenic differentiation of TSPCs by enhancing the production of miRNA (miR)-217 and thus decreasing the expression of EGR1, a direct target of miR-217. Our results may offer a possible target for the prevention or treatment of tendon aging and degeneration.
Materials and Methods

Isolation and culture of human TSPCs
Human TSPCs were isolated from Achilles tendons obtained from different donors, young/healthy (25 ± 8 years, Y-TSPC) and aged/ degenerated (65 ± 10 years, A-TSPC), as described previously [13] and cultured in Dulbecco's modified Eagle's medium supplemented with 10% of fetal bovine serum, 1% of a penicillin-streptomycin solution, and 2 mM L-glutamine. The cells were used at passages 3-6. The procedure was approved by the Ethical Commission of Capital Medical University, and informed consent was obtained from all the donors.
Senescence-associated β-galactosidase staining Senescence assays were performed using the senescence-associated β-galactosidase (SA-β-gal) staining kit (Beyotime, Haimen, China) according to the manufacturer's instructions. TSPCs were washed with PBS and fixed for 15 min with 3% formaldehyde. After another wash with PBS, the cells were stained overnight with the β-gal solution. Then, β-gal-positive cells (blue color) were counted and expressed in percentage versus the total number of cells.
Lentivirus transduction and miRNA transfection
The lentiviral vectors encoding p16 or EGR1 were purchased from Hanbio (Shanghai, China). Viral production and infection were performed according to the manufacturer's instructions. Briefly, the lentiviral vectors were transfected into 293T cells along with the lentiviral packaging mix. After 48 h, the viral supernatants were collected, filtered, and concentrated. Y-TSPCs or A-TSPCs were transduced with viral particles and purified 48 h after transduction by puromycin selection. TSPCs were transfected with miR-217 mimics or a miR-217 inhibitor (Ribobio, Guangzhou, China) using Lipofectamine 2000 (Invitrogen, Carlsbad, USA). After 48 h, the cells were harvested for mRNA or protein analysis.
RNA preparation and quantitative RT-PCR
Total RNA was extracted from cells with the Trizol Reagent (Invitrogen) and was reverse-transcribed (2 μg) using oligo (dT) primers and M-MLV reverse transcriptase (Promega, Madison, USA). Quantitative RT-PCR (qRT-PCR) was performed with the SYBR Premix Ex Taq II (TaKaRa, Dalian, China). RNU6B and β-actin served as endogenous normalization controls for miR-217 and mRNAs, respectively. The data were analyzed using the 2 −ΔΔCt method. All the samples were examined in triplicate. The primers for PCR were shown in Table 1 . PCR conditions were as follows: 94°C for 5 min, 40 cycles of 30 s at 94°C for denaturation, 30 s at 60°C for annealing, and 30 s at 72°C for elongation, and finally 5 min at 72°C.
Western blot analysis
Total protein samples were extracted from cells with RIPA buffer. Protein concentrations were quantified by using the BCA reagent kit (BioTek, Shanghai, China). Proteins were separated by SDS-PAGE in a 10% gel, and transferred to a polyvinylidene difluoride (PVDF) membrane. After 1 h of blocking with 5% non-fat milk, the membranes were incubated with an anti-EGR1 (Abcam, Cambridge, USA), anti-p16
Biotechnology, Santa Cruz, USA) overnight at 4°C. Following TBST washes, the membranes were incubated with a horseradish peroxidase (HRP)-conjugated secondary antibody for 1 h at 37°C, and protein bands were finally detected using an enhanced chemiluminescence detection kit (Pierce, Rockford, USA).
Enzyme-linked immunosorbent assay
The cell lysates were collected after cells were lyzed with RIPA buffer. The concentration of Type I collagen (Col1) in the cell lysates 
Forward, 5′-AAGGCATTCGTGGCGATAAG-3′ Reverse, 5′-ACCACCGCTTACACCTGGAG-3′ Col3
Forward, 5′-GCTGCCATTGCTGGGATTG-3′ Reverse, 5′-TCTGCAGTTTCTAGCGGGGT-3′ EGR1
Forward, 5′-CCACGCCGAACACTGACATT-3′ Reverse, 5′-GAGAAGCGGCGATCACAGGA-3′
was measured using an enzyme-linked immunosorbent assay (ELISA) kit (BioLeaf, Shanghai, China). Absorbance was determined at 450 nm with a microplate reader (Bio-Rad, Hercules, USA). The results were compared with a standard curve constructed by using a standard Col1 solution.
Plasmid construction and dual-luciferase reporter assay
To construct a luciferase reporter vector, the wild-type UTR of EGR1, containing the putative binding site for miR-217, was cloned downstream of the firefly luciferase reporter gene of the pGL3 control vector (Promega). The corresponding mutant construct was generated by mutating the seed region of the miR-217-binding site. HEK293T cells were seeded on 24 plates and co-transfected with miR-217 mimics or negative control (NC) and the wild-type or mutant reporter plasmid, together with Renilla luciferase construct that was used as a normalization reference. Transfection was performed using Lipofectamine 2000 transfection reagent. Luciferase and Renilla signals were measured 48 h after transfection, using the dual-luciferase reporter assay kit (Promega) according to the protocol provided by the manufacturer.
Statistical analysis
All experiments were conducted at least in triplicate, and experimental data were expressed as the mean ± SD. Two-group differences were analyzed by Student's t-test using the SPSS software, version 13.0. P < 0.05 were considered significant.
Results
The tenogenic differentiation capacity of TSPCs significantly decreases with advancing age
To assess the tenogenic differentiation ability with advancing age in TSPCs, Y-TSPCs, and A-TSPCs were isolated from Achilles tendons of young and aged donors, respectively. In A-TSPCs, the proportion of SA-β-gal-positive cells was significantly greater as compared with Y-TSPCs (Fig. 1A) , and p16 was also markedly upregulated at mRNA and protein levels (Fig. 1B) . The tenogenic differentiation capacity of TSPCs derived from aged donors was significantly lower compared with those obtained from young donors, according to the mRNA expressions of tendon-related markers. As shown in Fig. 1C , scleraxis (Scx), tenomodulin (Tnmd), biglycan (Bgn), decorin (Dcn), Col1, and Type III collagen (Col3) were all significantly downregulated in A-TSPCs compared with Y-TSPCs. Furthermore, ELISA results showed that Col1 concentration was also significantly decreased in A-TSPCs (Fig. 1D ) when compared with that in Y-TSPCs.
p16 is responsible for the inhibition of tenogenic differentiation of TSPCs
Given that A-TSPCs have a significantly higher p16 expression level, we then investigated the relation between p16 and tenogenic differentiation capacity of TSPCs. Y-TSPCs were stably transduced with a lentivirus encoding p16 or with a control lentivirus. After 48 h, upregulation of p16 was confirmed by qRT-PCR and western blot analysis ( Fig. 2A) . Next, we performed SA-β-gal staining to compare the senescence states of p16-overexpressing TSPCs and control TSPCs. The results revealed that p16 overexpression induced a , were assessed by qRT-PCR and western blot analyses. (C) qRT-PCR analyses of tendon-related markers: Scx, scleraxis; Tnmd, tenomodulin; Bgn, biglycan; Dcn, decorin; Col1, Type I collagen; Col3, and Type III collagen. (D) Type I collagen concentration in the cell lysate was measured by an ELISA. Data are expressed as the mean ± SD of three independent experiments. *P < 0.05. significant increase in the proportion of SA-β-gal-positive cells (Fig. 2B) . Moreover, it was found that exogenous p16 could also significantly decrease the expression of tendon-related markers (Fig. 2C) and the concentration of Col1 as compared with the control (Fig. 2D) .
p16 inhibits tenogenic differentiation of TSPCs by promoting the transcription of miR-217
Considering that miRNAs are novel effectors of p16 [15] and some previous research showed that miR-217 is progressively expressed in cells with aging [19] , we evaluated the expression pattern of miR-217 in Y-TSPCs and A-TSPCs. The results showed that the miR-217 was significantly increased in A-TSPCs compared with that in YTSPCs (Fig. 3A) . Furthermore, p16 upregulation in Y-TSPCs enhanced the expression of miR-217, suggesting that p16 may have a positive effect on the production of miR-217 (Fig. 3B) . Because miR-217 was substantially upregulated in A-TSPCs, we next used miR-217 inhibitor to down-regulate miR-217 in A-TSPCs. Figure  3C and Supplementary Fig. S1 showed that inhibition of miR-217 decreased the proportion of SA-β-gal-positive cells as compared with the control. qRT-PCR analysis suggested that the expressions of tendon-related markers were noticeably enhanced after inhibition of miR-217 expression (Fig. 3D) . Furthermore, Col1 concentration was significantly increased in miR-217-deficient A-TSPCs compared with control cells (Fig. 3E) .
EGR1 plays an important role in the p16/miR-217 cascade during tenogenic differentiation of TSPCs Analysis using three bioinformatics algorithms (TargetScan, pictar, and miRanda) indicated that EGR1, a transcription factor which directs tendon differentiation [20] , is a likely molecular target of miR-217. Therefore, we further performed luciferase reporter assay to determine whether miR-217 could directly target the 3′UTR of EGR1. The results showed that miR-217 overexpression decreased the EGR1 3′UTR luciferase reporter activity, and this effect was abolished when the three nucleotides in the miR-217 seed binding site of the EGR1 3′UTR were mutated (Fig. 4A) . qRT-PCR and western blot analysis results indicated that the expression of EGR1 was decreased after upregulation of p16 in Y-TSPCs (Fig. 4B) . Then, we transfected p16-overexpressing Y-TSPCs with a miR-217 inhibitor and determined EGR1 expression by western blot analysis. As shown in Fig. 4C , the EGR1 level in these cells was almost the same as that in the untreated cells, suggesting that p16 affects the expression level of EGR1 mainly through miR-217. We also analyzed the expression of EGR1 in Y-TSPCs and A-TSPCs. The results showed that the EGR1 level was significantly lower in A-TSPCs than in Y-TSPCs (Fig. 4D) . Next, EGR1-overexpressing A-TSPCs were transfected with miR-217 mimics, and cellular aging and the capacity for tenogenic differentiation were examined. As shown in Fig. 4E and Supplementary Fig. S2 , senescence of A-TSPCs could be partially rescued after up-regulating EGR1 expression. However, this effect was abolished after miR-217 overexpression by miR-217 mimics. The tenogenic differentiation ability of A-TSPCs was significantly enhanced after upregulation of EGR1 expression. In contrast, the increase of miR-217 expression by miR-217 mimics reversed this stimulatory effect (Fig. 4F,G) .
Discussion
TSPCs residing in tendons are responsible for tissue homeostasis and for the maintenance and repair of the tissue after trauma [3] . With advancing age, the ability of tissues to repair themselves diminishes, which may be due to reduced functional capacity of the Type I collagen concentration in the cell lysate was measured by ELISA. Data are expressed as the mean ± SD of three independent experiments. *P < 0.05. p16 regulates tenogenic differentiation of TSPCs progenitor cells [13, 21] . Therefore, our study aimed to assess the effects of age on the capacity of TSPCs for tenogenic differentiation and to explore the possible molecular mechanisms.
There are apparently conflicting data about the influence of aging on the differentiation potential of stem and progenitor cells. Some studies have shown that young and old MSCs have similar differentiation potentials [22, 23] . Others have revealed that progenitor cells show an age-dependent decrease in the differentiation potential [9, 21, 24] , which may be a causative factor in a number of agerelated pathologies such as arthritis, tendinosis, and osteoporosis. In the present study, we detected obvious changes in the tenogenic differentiation potential of aged versus young TSPCs. TSPCs from elderly donors showed upregulation of SA-β-gal and p16 and concurrently a decrease in Type I collagen concentration and in the expressions of tendon-related markers: Scx, Tnmd, Bgn, Dcn, Col1, and Col3. Of note, p16 overexpression in young TSPCs induced a significant decrease in the expression of tendon-related markers and the concentration of Col1, suggesting that upregulation of the p16 pathway with age may play a critical role in the reduction of tenogenic differentiation in TSPCs. This result is consistent with the results of other studies [10, 14] .
miRNAs perform an important function in senescence and differentiation of progenitor cells [25] [26] [27] . For example, the miRNA cluster miR-106b-25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation, and is a part of a network involving insulin/insulin-like growth factor-1 (IGF) signaling: a pathway implicated in aging [28] . p53 and p16 are not only senescence markers but also transcription regulators. p53 contributes to the bone mass loss in age-related osteoporosis. p53 overexpression inhibits osteogenesis in young MSCs by inhibiting the transcription of the miR-17-92 cluster, which is decreased in old mice [10] . It has been reported that p16 positively regulates the transcription of miR-141 and miR-146b-5p through physical interaction with CDK4 and transcription factor Sp1 in response to ultraviolet-light-induced DNA damage [15] . Recently, the same research team found that p16 controls senescence and epithelial-mesenchymal transition of human fibroblasts and breast cancer cells by repressing an epithelialmesenchymal-transition-related transcription factor via miR-141/ miR-146b-5p and their target AUF1 [29] . A previous study showed that miR-217 is progressively expressed in endothelial cells with aging. In young human endothelial cells, miR-217 induces a premature-senescence-like phenotype and leads to impairment of angiogenesis. Conversely, inhibition of miR-217 in old endothelial cells ultimately reduces senescence and increases angiogenic activity [19] . MiR-217 overexpression induces a senescence phenotype in young fibroblasts, whereas miR-217 downregulation in old fibroblasts partially reverses the senescence phenotype [30] . In the present study, we found that the miR-217 level is significantly increased in aged TSPCs compared with young TSPCs, and p16 has a positive effect on the transcription of miR-217. In addition, we demonstrated that EGR1, a target of miR-217, promotes tenogenic differentiation in TSPCs. Indeed, the expression of EGR1 is lower in aged TSPCs than in young TSPCs, and an upregulation of p16 decreases EGR1 expression as well. Furthermore, ectopic expression of EGR1 enhances the tenogenic differentiation capacity in aged TSPCs with upregulated p16, while an increase in miR-217 expression induced by miR-217 mimics reverses this stimulatory effect, suggesting that p16 inhibits the tenogenic differentiation of TSPCs through enhancing the transcription of miR-217 and thereby decreasing the expression of EGR1.
In summary, our results provide clear evidence that TSPC senescence involves a reduction in the tenogenic differentiation potential. Senescence marker p16 can inhibit tenogenic differentiation of TSPCs via miRNA signaling pathways. This study reveals a novel mechanism of age-related tenogenic differentiation and may offer a new possible target for the prevention or treatment in the future.
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